This disclosure relates to the use of
dielectric spectroscopy for selecting cells, typically cells engineered by recombinant methods, but also to
hybridoma cell lines that produce antibodies and express peptides such as antibodies; CAR-T cells; induced pluripotent stem (IPS) cells; and cells derived from IPS cells.